ADVB Advanced Biomed Inc. Common Stock
Healthcare$3.98+1.53%ClosedMarket Cap: $4.3M
As of 2026-05-26
Valuation
P/E (TTM)
28.20
PEG
0.01
P/B
17.62
P/S
0.00
EV/EBITDA
-7.79
DCF Value
$141.41
FCF Yield
-2.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-19.6%
ROA
-61.3%
ROIC
-190.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | -Infinity% | $-16.4K | $-15.5K | $— | — |
| Q2 null | $0.00 | -Infinity% | $-12.8K | $220.9K | $— | — |
| Q1 null | $0.00 | NaN% | $-523.9K | $-386.9K | $— | — |
| Q4 null | $0.00 | -Infinity% | $-39.3K | $-22.7K | $— | — |
| FY null | $0.00 | -Infinity% | $-94.1K | $-101.5K | $— | — |
| Q3 null | $0.00 | NaN% | $-762.7K | $-1.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-8.7K | $-28.1K | $— | — |
| Q1 null | $0.00 | NaN% | $-520.0K | $-265.6K | $— | — |
| Q4 null | $0.00 | NaN% | $-704.6K | $-809.4K | $— | — |
| FY null | $0.00 | NaN% | $-2.5M | $-2.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-745.4K | $-1.1M | $— | — |
| Q2 2024 | $0.00 | NaN% | $-651.3K | $-145.3K | $-0.01 | — |